跳至主要内容
临床试验/NCT01825005
NCT01825005已完成不适用

Predicting Outcome in Cervix Carcinoma: a Prospective Study

Maastricht Radiation Oncology2 个研究点 分布在 2 个国家目标入组 423 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
423
试验地点
2
主要终点
five-year overall survival rate

研究概览

简要总结

The main aim is to validate and improve the predictive model for survival and toxicity in patients with cervical cancer through multicentric prospective data collection. The data contain information on patient, tumor and treatment characteristics. For this study, additional health related QOL scores will be assessed using the EORTC Quality of Life Questionair-CX24 and C30. The long term aim, beyond this specific study, is to build a Decision Support System based on the predictive model validated in this study.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • histological or cytological proven cervical cancer
  • informed consent according to national rules

排除标准

  • no histological or cytological proven cervical cancer
  • no informed consent according to national rules

结局指标

主要结局

five-year overall survival rate

时间窗: 5 years after treatment

assessment of the overall survival 5 years after treatment

次要结局

  • three-year distant disease free survival(3 years)
  • three-year local disease free survival(3 years)
  • five-year distant disease free survival(5 years)
  • five-year local disease free survival(5 years)
  • number of participants with early adverse events as a measure of safety and tolerability(2 months)
  • number of participants with late adverse events as a measure of safety and tolerability(5 years)

研究者

发起方
Maastricht Radiation Oncology
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验